MicroRNA-4513 Promotes Gastric Cancer Cell Proliferation and Epithelial-Mesenchymal Transition Through Targeting...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Gastric cancer (GC) remains a significant global health challenge.
• Understanding the molecular mechanisms driving GC progression is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the expression of microRNA-4513 (miR-4513) in gastric cancer (GC).
• To elucidate the regulatory mechanisms of miR-4513 in GC progression.
• To explore the potential of miR-4513 as a therapeutic target for GC.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to measure miR-4513 expression.
• Cell proliferation and invasion assays (Cell Counting Kit-8, Transwell assay).
• Western blot analysis for epithelial-mesenchymal transition (EMT) markers and KAT6B.
• Bioinformatic analysis to identify miR-4513 targets.

Main Results:

• miR-4513 expression was significantly upregulated in GC cell lines.
• Downregulation of miR-4513 inhibited GC cell proliferation, invasion, and EMT.
• Lysine acetyltransferase 6B (KAT6B) was identified as a direct target of miR-4513.
• miR-4513 regulates GC progression through KAT6B.

Conclusions:

• miR-4513 plays a critical role in promoting GC cell proliferation, invasion, and EMT.
• The miR-4513/KAT6B axis is a key regulator of gastric cancer progression.
• miR-4513 represents a promising molecular target for GC therapy.